# Low-dose radiation therapy for idiopathic or interstitial cystitis in male cats

**Authors:** Allison Kendall, Shelly Vaden, Tracy Gieger, Tonya Harris, Margaret E Gruen, Michael W Nolan

PMC · DOI: 10.1093/jvimsj/aalaf029 · Journal of Veterinary Internal Medicine · 2026-01-21

## TL;DR

Low-dose radiation therapy improved symptoms in male cats with chronic urinary tract issues, offering a promising new treatment option.

## Contribution

Demonstrates the feasibility and effectiveness of low-dose radiation therapy for managing feline idiopathic cystitis.

## Key findings

- Over 90% of treated cats showed improvement in clinical signs with no adverse effects.
- Six cats experienced a single flare-up of symptoms after a median of 243 days post-treatment.
- One cat had a recurrent urethral obstruction managed surgically after radiation therapy.

## Abstract

Idiopathic cystitis (IC) accounts for the majority of lower urinary tract (LUT) disease in cats and is characterized by recurrent clinical signs or urethral obstruction (UO), presenting ongoing challenges in clinical management.

Determine the feasibility of using single-fraction low-dose radiotherapy (RT) to reduce rate of re-obstruction and recurrence of clinical signs in cats with feline idiopathic cystitis.

Fifteen client-owned male cats with recent history of severe IC and historical UO that remained symptomatic despite environmental modification and pharmacological management.

An IACUC-approved, single-arm, single-institution, prospective clinical trial was conducted to evaluate the clinical effects of irradiating the entire LUT with a single 6 Gy fraction.

One cat was immediately lost to follow-up, and 1 died 516 days after RT. The remaining 13 cats were alive at the time of data analysis, with a median follow-up of 548 (range 70-1307) days. All but 1 had symptomatic improvement. Six had a single flare-up of signs of IC at a median of 243 days after RT (range 4-395 days). After RT, 1 cat had a recurrent UO, which occurred at 11 months and was managed surgically.

In this cohort of severely affected cats, >90% had apparent improvement in clinical signs after RT, with no documented adverse effects, demonstrating that in addition to environmental modification, RT is a promising tool for managing IC in male cats.

## Linked entities

- **Diseases:** urethral obstruction (MONDO:0001556)

## Full-text entities

- **Diseases:** urolithiasis (MESH:D052878), toxicosis (MESH:C565846), toxicity (MESH:D064420), CBC (MESH:D006402), UO (MESH:D014524), UA abnormality (MESH:D000014), urethral muscle spasm (MESH:D013035), pyuria (MESH:D011776), LUT disease (MESH:D014570), lick granulomas (MESH:D006099), PU (MESH:D009437), depression (MESH:D003866), chronic pain (MESH:D059350), renal disease (MESH:D007674), bladder pain syndrome (MESH:D018856), lymphoplasmacytic rhinitis (MESH:D012220), bacteriuria (MESH:D001437), anxiety (MESH:D001007), cancer (MESH:D009369), urethral tear (MESH:D014526), meningoencephalitis (MESH:D008590), hyperkalemia (MESH:D006947), pain (MESH:D010146), hematuria (MESH:D006417), trauma (MESH:D014947), osteosarcoma (MESH:D012516), inflammation (MESH:D007249), FIC (MESH:D002371), colonic tumor (MESH:D003110), lower (MESH:D017116), rupture of the urinary bladder (MESH:D001745), IC (MESH:D003556), hypotension (MESH:D007022), stricture (MESH:D003251), osteoarthritis (MESH:D010003), azotemia (MESH:D053099), neurologic disease (MESH:D020271), tachycardia (MESH:D013610)
- **Chemicals:** IC (-), creatinine (MESH:D003404), gabapentin (MESH:D000077206), buprenorphine (MESH:D002047), amitriptyline (MESH:D000639), fluoxetine (MESH:D005473), prazosin (MESH:D011224), robenacoxib (MESH:C551524), phosphate (MESH:D010710), nitric oxide (MESH:D009569)
- **Species:** Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606], Canis lupus familiaris (dog, subspecies) [taxon 9615]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881965/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12881965/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12881965/full.md

---
Source: https://tomesphere.com/paper/PMC12881965